V. Jayde
Fox Chase Cancer Center(US)Royal Hobart Hospital(AU)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, DNA Repair Mechanisms, BRCA gene mutations in cancer, Immune Cell Function and Interaction
Most-Cited Works
- → Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma(2018)282 cited
- → Prognostic gene expression signature for high-grade serous ovarian cancer(2020)170 cited
- → Symptoms and diagnostic delay in ovarian cancer: A summary of the literature(2010)55 cited
- → The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer(2013)45 cited
- → Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses(2020)38 cited
- → MyD88 and TLR4 Expression in Epithelial Ovarian Cancer(2018)30 cited
- → BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance(2024)24 cited
- → Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer(2024)14 cited
- → The diagnostic journey of ovarian cancer: A review of the literature and suggestions for practice(2012)13 cited
- → Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer(2023)5 cited